Tempest to Present at the H.C. Wainwright 28th Annual Global Investment Conference Life Science Investing
Optimi Health to Participate in the H.C. Wainwright 28th Annual Global Investment Conference Psychedelics Investing
Surrozen Announces Submission of IND Application for SZN-8141 for the Treatment of Diabetic Macular Edema Life Science Investing
Clinical Trial for an Oral Drug to Treat Ebola is Registered in the Pan African Clinical Trials Database and is Ready to Go, As the Largest Ebola Outbreak Continues to Expand in DR Congo Life Science Investing
Eupraxia Pharmaceuticals Completes Transfer to the Nasdaq Global Select Market and Announces Participation in Upcoming Investor Conferences Life Science Investing
Anavex Life Sciences to Host Investor Call on Wednesday, September 9, 2026, at 4:00 PM ET Life Science Investing
Johnson & Johnson spotlights new neuropsychiatry data across bipolar mania, depression and schizophrenia at Psych Congress 2026 Pharmaceutical Investing
Charles River Modernizes Endosafe® Endotoxin Testing Cartridge Manufacturing with Fully Automated Production Suite Life Science Investing
Lexaria Announces Exercise of Warrants for Approximately $5.9 Million in Gross Proceeds Biotech Investing
Dyne Therapeutics to Present Additional One-Year Clinical Data from Phase 1/2 ACHIEVE Trial of Z-Basivarsen for Myotonic Dystrophy Type 1 at Upcoming Medical Meetings Life Science Investing
BriaCell's Pivotal Phase 3 Metastatic Breast Cancer Study Expands to Leading Cancer Center Pharmaceutical Investing
